Patients With Valvular Heart Disease Presenting With Sustained Ventricular Tachyarrhythmias or Syncope
Authors:
- 15 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (2) , 500-508
Abstract
Background Programmed ventricular stimulation is commonly used to guide therapy in post–myocardial infarction patients with sustained monomorphic ventricular tachycardia (VT) or ventricular fibrillation (VF). In patients with valvular heart disease presenting with spontaneous VT, VF, or syncope, the usefulness of this technique is still unclear. The aim of the study was to analyze whether programmed ventricular stimulation was helpful in guiding therapy and determining prognosis in 97 patients with valvular heart disease presenting with VT (60%), VF (18%), or syncope (22%). Methods and Results Patients were classified as having either predominant ventricular pressure or volume overload or no significant pressure or volume overload. Overall, sustained VT or VF was inducible in 38 (39%) and 19 (20%) patients, respectively. Forty-six (47%) patients were discharged on antiarrhythmic drugs, 29 (30%) received an implantable cardioverter-defibrillator, and 22 (23%) remained without therapy. With serial drug testing, inducibility was completely or partially suppressed in 18 (19%) and 9 (9%) patients, respectively. During a mean follow-up of 51 months (n=97), 17 patients (18%) died (sudden death, n=7; heart failure, n=4; noncardiac causes, n=6). One-, 2- and 3-year event-free survival for sudden death, sustained VT, or VF was 77%, 68%, and 61%, respectively. Only inducibility of VT during baseline study ( P <.0003) and left ventricular volume overload ( P <.008) were significant predictors of arrhythmic events. Recurrence of arrhythmic events occurred in 56% and 56% of patients with complete or partial suppression of inducibility during serial drug testing as well as in 10 of 19 (53%) patients without a change in inducibility. Conclusions Although programmed ventricular stimulation seems to predict adverse outcome, serial drug testing is unreliable in guiding therapy. The type of workload imposed on the ventricles influences outcome, being worse in patients with left ventricular volume overload. Therefore, implantation of a cardioverter-defibrillator should be considered early for the management of these patients.Keywords
This publication has 26 references indexed in Scilit:
- Sudden cardiac death while wearing a Holter monitorThe American Journal of Cardiology, 1991
- Slow conduction in the infarct scar: Relevance to the occurrence, detection, and ablation of ventricular reentry circuits resulting from myocardial infarctionAmerican Heart Journal, 1989
- Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 casesAmerican Heart Journal, 1989
- The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmiasAmerican Heart Journal, 1985
- Ventricular arrhythmias in aortic valve disease: Analysis of 102 patientsThe American Journal of Cardiology, 1984
- Mitral valve prolapse in the general population. I. Epidemiologic features: The Framingham StudyAmerican Heart Journal, 1983
- Determinants of the incidence and severity of ventricular arrhythmias in aortic valve diseaseThe American Journal of Cardiology, 1983
- Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis.Circulation, 1978
- Ischemia in aortic stenosis: Hemodynamic predictionThe American Journal of Cardiology, 1975
- Quantitative changes in the capillary-muscle relationship in human hearts during normal growth and hypertrophyAmerican Heart Journal, 1941